BPSD Clinical Trial
Official title:
Amisulpride Versus Olanzapine Treatment for Behavioral and Psychological Symptoms in Patients With Dementia of the Alzheimer Type:A Randomized, Open-label, Prospective Study
Currently, olanzapine is the most widely used and studied drug for the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease, but there are significant side effects. Amisulpride is a new antipsychotic that not only controls mental symptoms but also improves cognitive function. Therefore, the aim of this study was to evaluate the effectiveness and tolerability of both amisulpride and Olanzapine for treating the behavioral and psychological symptoms of dementia in patients with dementia of the Alzheimer type.
This study was a randomized, open-label, prospective clinical study in which patients were randomized to receive amisulpride and olanzapine for 8 weeks. Drug efficacy and safety assessments were assessed at baseline, 2 weekends, 4 weekends, and 8 weekends. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04985305 -
Optimization of Deprescribing Antidepressants in Nursing Home Residents With Dementia
|
N/A | |
| Not yet recruiting |
NCT06359704 -
Intervention for Emotions in Caregivers of Dementia
|
N/A | |
| Terminated |
NCT02415504 -
Comprehensive Care Transition: A Trial of an Enhanced Care Transition Process in Dementia
|
N/A | |
| Active, not recruiting |
NCT03108781 -
The Role of Aromatherapy With Lavender Oil in the Long-term Care on a Patients Behavioral Problems Associated With Dementia
|
N/A | |
| Completed |
NCT03303638 -
Investigating the Impact of Multi-sensory Environments on Behavior During Assisted Bathing for Veterans With Dementia
|
N/A |